| 000 | 01390 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518090556.0 | ||
| 264 | 0 | _c20210329 | |
| 008 | 202103s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2020.104730 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaini, Ramesh Kumar | |
| 245 | 0 | 0 |
_aProtective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: An update on epidemiological and mechanistic perspectives. _h[electronic resource] |
| 260 |
_bPharmacological research _c05 2020 |
||
| 300 |
_a104730 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aLycopene _xpharmacology |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasms _xepidemiology |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xepidemiology |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 700 | 1 | _aRengasamy, Kannan R R | |
| 700 | 1 | _aMahomoodally, Fawzi M | |
| 700 | 1 | _aKeum, Young-Soo | |
| 773 | 0 |
_tPharmacological research _gvol. 155 _gp. 104730 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2020.104730 _zAvailable from publisher's website |
| 999 |
_c30699858 _d30699858 |
||